Close mobile menu×
Close mobile menu

Elizabeth J. Shane, MD

Board Certifications: 
Endocrinology, Internal Medicine
Not Accepting New Patients

Appointments

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor

Board Certifications

  • Endocrinology
  • Internal Medicine

Clinical Expertise

  • Research Studies

Education & Training

  • University of Toronto Faculty of Medicine (Canada)
  • Residency: Columbia Presbyterian Medical Center, NY
  • Fellowship: Columbia Presbyterian Medical Center, NY

About Elizabeth Shane

Elizabeth Shane, M.D. is Professor of Medicine, Vice Chair of Medicine for Clinical and Epidemiological Research at Columbia University, College of Physicians and Surgeons in New York City and attending physician at NewYork-Presbyterian Hospita/Columbia University Medical Center.

Dr. Shane received her undergraduate training at Dalhousie University and her medical degree from the University of Toronto in Canada. She completed her medical internship at the Toronto General Hospital and her medical residency on the Medical Service of Columbia Presbyterian Medical Center in New York City. She did her training in Endocrinology and Metabolism at the College of Physicians and Surgeons and the Presbyterian Hospital in New York.

Academic Titles

  • Professor of Medicine at NewYork-Presbyterian/Columbia University Medical Center

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
180 Fort Washington Avenue
Suite 9-910
New York, New York 10032
Phone:
(212) 305-2042
Primary

Research

Dr. Shane's research interests include osteoporosis associated with organ transplantation, osteoporosis in premenopausal women, bone disease associated with HIV infection, and many secondary forms of osteoporosis such as renal bone disease and bone loss due to medications and disorders of the gastrointestinal tract. She is PI on several NIH grants, including one to investigate idiopathic osteoporosis in premenopausal women, and others on bone disease in HIV-infected postmenopausal women and the utility of high resolution peripheral QCT scanning to characterize bone microarchitecture in various bone diseases associated with fractures. Dr. Shane was Associate Editor of the Journal of Clinical Endocrinology and Metabolism (2000-2004), Associate Editor of the First through Sixth Editions of the Primer of the Metabolic Bone Diseases and Disorders of Mineral Metabolism, and currently serves on the Editorial Boards of Bone and the Journal of Bone and Mineral Research. Dr. Shane belongs to a number of professional societies including the American Society for Bone and Mineral Research (ASBMR), the Endocrine Society, and International Society for Clinical Densitometry and the American Association for Clinical Endocrinologists. She has served on the Council for the American Society for Bone and Mineral Research (ASBMR), as Program Chair for the 2001 Annual Meeting, as President of ASBMR, and is currently the ASBMR representative to the Board of Directors of FASEB. She chaired or co-chaired three ASBMR Task Forces, on Ethics in Publishing in 2005, Osteonecrosis of the Jaw in 2006-7 and Atypical Femur Fractures in 2009-10.

Research Interests

  • My research is focused on osteoporosis and other disorders of bone and mineral metabolism. I am particularly interested in the multiple intersections between the skeleton and other diseases (such as HIV/AIDS) and medications (glucocorticoids, cyclosporines, heparin).

Grants

BISPHOSPHONATES FOR PREVENTION OF POST-DENOSUMAB BONE LOSS IN PREMENOPAUSAL WOMEN WITH IDIOPATHIC OSTEOPOROSIS (P&S Industry Clinical Trial)

Feb 7 2018 - Feb 7 2023

PHASE 2B STUDY OF DENOSUMAB TO PREVENT BONE LOSS IN IDIOPATHIC OSTEOPOROSIS IN PREMENOPAUSAL WOMEN TREATED WITH TERIPARATIDE (Federal Gov)

Jul 1 2016 - Jun 30 2020

TERIPARATIDE FOR IDIOPATHIC OSTEOPOROSIS IN PREMENOPAUSAL WOMEN: A PHASE 2 STUDY (Federal Gov)

Sep 15 2011 - Dec 31 2019

DENOSUMAB FOR THE PREVENTION OF POST-TERIPARATIDE BONE LOSS IN PREMENOPAUSAL WOMEN WITH IDIOPATHIC OSTEOPOROSIS (P&S Industry Clinical Trial)

Dec 15 2014 - Dec 15 2019

HIV AND THE MENOPAUSAL TRANSITION: EFFECTS ON MUSCULOSKELETAL HEALTH (Federal Gov)

May 1 2011 - Apr 30 2018

VITAMIN D DEFICIENCY IN PRIMARY HYPERPARATHYROIDISM (Federal Gov)

Jul 1 2010 - Apr 30 2017

A NEW SYSTEM FOR ULTRASONIC ASSESSMENT OF THE CALCANEUS (Federal Gov)

Nov 1 2014 - Oct 31 2016

IDIOPATHIC OSTEOPOROSIS IN PREMENOPAUSAL WOMEN (Federal Gov)

Sep 5 2005 - Aug 31 2016

OSTEOPOROSIS IN HIV INFECTED POSTMENOPAUSAL WOMEN (Federal Gov)

Jul 1 2010 - Jun 30 2016

CLINICAL BONE MECHANICS USING HR-PQCT AND MRI (Federal Gov)

Jul 1 2010 - Apr 30 2015

A PHASE IIB,RANDOMIZED DOUBLE-BLIND,PLACEBO -AND ACTIVE-CONTROLLED,DOSE-RANGE-FINDING STUDY TO EVALUATE THE EFFECTS OF (P&S Industry Clinical Trial)

Jan 12 2010 - Jan 21 2015

ULTRASONIC ASSESSMENT OF THE FOREARM (Federal Gov)

Apr 15 2010 - Dec 31 2013

ELI LILLY - AAAC6871 (P&S Industry Clinical Trial)

Jun 24 2008 - Dec 31 2013

RANDOMIZED TRIAL OF ACTIVE VITAMIN D, CHOLECALCIFEROL AND PL ACEBO FOR CKD-MBD (Federal Gov)

Jul 1 2011 - Jun 30 2013

ZOLEDRONIC ACID VERSUS ALENDRONATE FOR PREVENTION OF BONE LOSS AFTER ORGAN TRANSPLANTATION (P&S Industry Clinical Trial)

Jun 2 2005 - Dec 31 2012

IDIOPATHIC OSTEOPOROSIS IN PREMENOPAUSAL WOMEN (Federal Gov)

Mar 25 2005 - Feb 29 2012

ULTRA-HIGH RESOLUTION PQCT AS A BIOMARKER OF BONE STRENGTH I N OSTEOPOROSIS TRIALS (Federal Gov)

Sep 1 2007 - Jul 31 2011